Saeed Sadeghi, MD, discusses valuable feedback he heard from oncologists on the use of luspatercept-aamt in patients with low-risk myelodysplastic syndrome.
Significant advancements in lung cancer treatment were seen throughout 2024, from new drug approvals to promising clinical ...
Akriti Jain, MD, discusses her presentation from the 2024 American Society of Hematology Meeting and Exposition.
A panelist discusses how infusion-related reactions to monoclonal antibodies in EGFR-mutated NSCLC can be effectively managed ...
Alfa, MD, discusses the findings and key takeaways from the SUMMIT trial, which evaluated the use of neratinib for the ...
During a Case-Based Roundtable® event, Daniel J. George, MD, discusses how often community oncology participants see patients ...
The FDA approved subcutaneous nivolumab for solid tumors, tiselizumab for advanced gastric and GEJ cancers, and key 2024 breast cancer breakthroughs are reviewed. Experts provide perspective on ...
Potential practice-changing therapies in gynecologic cancer include the emergence of carboplatin, paclitaxel, and PD-1 ...
Pancreatic ductal adenocarcinoma remains a challenge to treat due to its complex biology and resistance mechanisms.
A new drug application seeking the accelerated approval of dordaviprone forrecurrent for H3K27M-mutant diffuse glioma ...
During an in-person Community Case Forum event in Miami, Florida, Mike Cusnir, MD, discussed the ARANOTE study outcomes ...
Experts examine both overall survival outcomes and independent review committee–assessed progression-free survival data from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback